Case closed: Neutrons settle 40-year debate on enzyme for drug design
Filter News
Area of Research
- (-) Nuclear Science and Technology (3)
- Advanced Manufacturing (1)
- Biology and Environment (10)
- Clean Energy (13)
- Computer Science (1)
- Fusion and Fission (1)
- Isotope Development and Production (1)
- Isotopes (7)
- Materials (13)
- Materials for Computing (2)
- National Security (14)
- Neutron Science (4)
- Quantum information Science (1)
- Sensors and Controls (1)
- Supercomputing (23)
News Topics
- (-) Isotopes (2)
- (-) Space Exploration (2)
- 3-D Printing/Advanced Manufacturing (2)
- Advanced Reactors (2)
- Bioenergy (1)
- Biomedical (1)
- Computer Science (1)
- Decarbonization (1)
- Fusion (1)
- Materials Science (1)
- Neutron Science (1)
- Nuclear Energy (7)
- Physics (1)
- Sustainable Energy (1)
- Transformational Challenge Reactor (1)
Media Contacts
After its long journey to Mars beginning this summer, NASA’s Perseverance rover will be powered across the planet’s surface in part by plutonium produced at the Department of Energy’s Oak Ridge National Laboratory.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.
With the production of 50 grams of plutonium-238, researchers at the Department of Energy’s Oak Ridge National Laboratory have restored a U.S. capability dormant for nearly 30 years and set the course to provide power for NASA and other missions.